| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/2005 | EP0792358B1 A polynucleotide tuberculosis vaccine |
| 06/01/2005 | EP0787189B1 Nucleotide sequences mediating male fertility and method of using same |
| 06/01/2005 | EP0656941B1 Methods for producing members of specific binding pairs |
| 06/01/2005 | CN1623092A Diagnostic methods |
| 06/01/2005 | CN1622997A Method for inspecting the genetic susceptibility of Helicobacter Pylorus related gastric carcinoma and the use thereof |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 06/01/2005 | CN1622955A Tumor tag and the use thereof |
| 06/01/2005 | CN1622830A Peptide-based compounds |
| 06/01/2005 | CN1622828A Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 06/01/2005 | CN1622823A Purification of red blood cells by separation and infiltration |
| 06/01/2005 | CN1622760A A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent |
| 06/01/2005 | CN1621524A Prokaryotic expression engineering bacteria for producing human recombinant interleukin-15 and its purifying method |
| 06/01/2005 | CN1621523A Adenosine phosphate-ribosylation-factor 1 gene in cotton and its promoter |
| 06/01/2005 | CN1621414A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof |
| 06/01/2005 | CN1621413A C-type agglutinin and genes encoding same |
| 06/01/2005 | CN1621412A High molecular wheat glutelin subunit, genes encoding same and use thereof |
| 06/01/2005 | CN1621411A Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome |
| 06/01/2005 | CN1621409A Novel growth related genes from swine |
| 06/01/2005 | CN1621341A Process for preparing water-soluble carbon nano tube coated with self-assembled material |
| 06/01/2005 | CN1204265C Method of concentrating and recovering a viral enzyme activity from biological samples |
| 06/01/2005 | CN1204256C Technology for detecting foot and mouth disease virus antibody of sick livestock using recombination foot and mouth disease vaccine gene expressing protein |
| 06/01/2005 | CN1204254C Protein DNA whose encoding makes colibacillus possess L-homoserine resistance and method for producing L-amino acid by using the same |
| 06/01/2005 | CN1204253C Neisseria lactoferrin binding protein |
| 06/01/2005 | CN1204251C Process for preparing VP2 protein from master host protective antigen (VP2) gene of infections burse disease virus (IBDV) and its gene engineering |
| 06/01/2005 | CN1204147C Method for enhancing circulating half-life of antibody-based fusion proteins |
| 06/01/2005 | CN1204145C Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
| 06/01/2005 | CN1204143C Crystalline forms of EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 06/01/2005 | CN1204142C Antigene V-erb B oligonucleotide and its use |
| 06/01/2005 | CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
| 05/31/2005 | US6900371 Pesticidal proteins |
| 05/31/2005 | US6900370 Generating cell with amplified mutant activity; obtain cell, transform with vector containing nucleotide sequence insert of preferential allele, recover cell and monitor mutational activity |
| 05/31/2005 | US6900368 Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 05/31/2005 | US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye |
| 05/31/2005 | US6900305 Isolated yeast promoter sequence and a method of regulated heterologous expression |
| 05/31/2005 | US6900304 Emission ratiometric indicators of phosphorylation |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 05/31/2005 | US6900292 Fusion protein for use in the treatment of anemia, cancer, arthritis and infections |
| 05/31/2005 | US6900290 Fractionation of whey proteins by complex formation |
| 05/31/2005 | US6900289 Physalia fluorescent proteins |
| 05/31/2005 | US6900288 Comprises membrane glycoproteins for diagnosis, prevention and treatment of nervous system and cell proliferative disorders |
| 05/31/2005 | US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications |
| 05/31/2005 | US6900185 Genetic engineering; binding Dna to apolipoprotein ligand; antitumor agents |
| 05/31/2005 | US6900177 Anticholesterol agents; cardiovascular disorders |
| 05/31/2005 | US6900056 Chemically defined medium for cultured mammalian cells |
| 05/31/2005 | US6900050 Comprises nucleotide sequences coding tumor necrosis factor receptor associated factor interacting protein (TRIP) for diagnosis and treatment of cell proliferative and apoptosis disorders |
| 05/31/2005 | US6900039 Catalytic oxidation of oligosaccharides |
| 05/31/2005 | US6900036 Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers |
| 05/31/2005 | US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors |
| 05/31/2005 | US6900034 Method for purifying recombinant proteins expressed as insoluble aggregates |
| 05/31/2005 | US6900033 Angiotensin converting enzyme-2/like polypeptides and inhibitors for treating and/or prevention of hypertension, congestive heart failure, stroke and atherosclerotic heart disease |
| 05/31/2005 | US6900032 Human PTTG polypeptide and method for producing it |
| 05/31/2005 | US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 05/31/2005 | US6900024 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells |
| 05/31/2005 | US6900022 Prostate cancer-specific marker |
| 05/31/2005 | US6900020 Identifying prorenin modulators for treatment of cardiovascular and organ hypertrophy; enzyme inhibitors; mimetics |
| 05/31/2005 | US6900017 Human hematopoietic growth regulatory gene and uses |
| 05/31/2005 | US6899885 74-kilodalton outer membrane protein from Moraxella catarrhalis |
| 05/31/2005 | US6899884 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/31/2005 | US6899882 Endothelial cell growth factor methods of isolation and expression |
| 05/31/2005 | US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES |
| 05/31/2005 | US6899880 Polypeptide vaccine; induce immunology response |
| 05/31/2005 | US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies |
| 05/31/2005 | US6899878 Antibodies to interleukin-1 receptor intracellular ligand proteins |
| 05/31/2005 | US6899875 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 05/31/2005 | US6899870 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 05/26/2005 | WO2005047905A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 22 (gpr22) |
| 05/26/2005 | WO2005047850A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 05/26/2005 | WO2005047546A2 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 05/26/2005 | WO2005047531A1 Assay for pkc-beta activation of phosphorylation of myosin heavy chain polypeptide |
| 05/26/2005 | WO2005047526A2 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
| 05/26/2005 | WO2005047518A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 05/26/2005 | WO2005047517A1 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis |
| 05/26/2005 | WO2005047516A2 Plant transcriptional regulators |
| 05/26/2005 | WO2005047514A1 Proteins involved in signal transduction |
| 05/26/2005 | WO2005047511A2 Bacterial expression of protease inhibitors and variants thereof |
| 05/26/2005 | WO2005047508A1 Processes for making acylated insulin |
| 05/26/2005 | WO2005047504A1 Induction of cellular senescence by cdk4 disruption for tumor suppression and regression |
| 05/26/2005 | WO2005047502A1 Protein library and screening method using the same |
| 05/26/2005 | WO2005047501A1 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| 05/26/2005 | WO2005047500A1 hERG CHANNEL-EXPRESSING CELL |
| 05/26/2005 | WO2005047494A2 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 05/26/2005 | WO2005047487A2 Motoneuronotrophic factor gene sequences |
| 05/26/2005 | WO2005047483A2 Renta: an hiv immunogen and uses thereof |
| 05/26/2005 | WO2005047481A2 Novel sequences encoding hapatitis c virus glycoproteins |
| 05/26/2005 | WO2005047478A2 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 05/26/2005 | WO2005047461A2 Polypeptide display libraries and methods of making and using thereof |
| 05/26/2005 | WO2005047460A2 Long-wavelength fps |
| 05/26/2005 | WO2005047459A2 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 05/26/2005 | WO2005047455A2 Methods for the production of apolipoproteins in transgenic plants |
| 05/26/2005 | WO2005047338A1 Cancer cell targeting gene delivery method |
| 05/26/2005 | WO2005047323A1 Dry recombinant human alpha 1-antitrypsin formulation |
| 05/26/2005 | WO2005047322A2 Factor viii compositions and methods |
| 05/26/2005 | WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof |
| 05/26/2005 | WO2005047319A2 Dna sequence and expressed recombinant glycoproteins related to feline thyrotropin |
| 05/26/2005 | WO2005047318A1 Gnal splice variant and uses thereof |
| 05/26/2005 | WO2005047317A1 Avidin mutants |